Skip to main content
SpringerLink
Log in

Japan's PMDA releases investigation results for 4 products

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Entecavir hydrate. Internet Document : 16 Feb 2016. Available from: URL: http://www.pmda.go.jp/files/000209890.pdf

  • PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Eribulin mesilate. Internet Document : 16 Feb 2016. Available from: URL: http://www.pmda.go.jp/files/000209889.pdf

  • PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Esomeprazole magnesium hydrate. Internet Document : 16 Feb 2016. Available from: URL: http://www.pmda.go.jp/files/000209888.pdf

  • PMDA - Pharmaceuticals and Medical Devices Agency. Summary of investigation results - Methylphenidate hydrochloride. Internet Document : 16 Feb 2016. Available from: URL: http://www.pmda.go.jp/files/000209887.pdf

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Japan's PMDA releases investigation results for 4 products. Reactions Weekly 1590, 3 (2016). https://doi.org/10.1007/s40278-016-15055-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-016-15055-5

Search

Navigation